In a retrospective study of more than 132,000 VA patients with type 2 diabetes, researchers found patients taking either metformin or thiazolidinediones had a lower risk of having colorectal polyps. Other medications, including aspirin and non-steroidal anti-inflammatory drugs, were associated with a lower risk of polypectomy.
The researchers also found risk factors for developing polyps in type 2 diabetes patients were increasing age, male gender, non-Hispanic white race and smoking, according to the news report.
Read the news report about insulin sensitizers and colon polyps.
Read other coverage about colorectal cancer:
– Two Samples in FIT Testing Improves Diagnostic Yield Without Affecting Attendance
– Interactive Voice Response System Just as Effective as Nurse Call for Endoscopy Completion
